ISRG - NASDAQ
Intuitive Surgical, Inc.
$407.29
+1.2%Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
At a Glance
Live SnapshotIntuitive Surgical, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Outstanding operational efficiency. The company generates substantial profit from core operations.
Net Profit Margin
Exceptional profitability. The company converts a significant portion of revenue to bottom-line earnings.
Effective Tax Rate
Below-average tax rate suggests effective tax planning, favorable jurisdictions, or tax credits.
Profitability Insight
Exceptional profitability across all levels: Strong pricing power, efficient operations, and healthy bottom line indicate a high-quality business with sustainable competitive advantages.
Intuitive Surgical, Inc. Income Statement
ISRG • NASDAQ
| Intuitive Surgical, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||||||||
10.1B | 8.4B | 7.1B | 6.2B | 5.7B | 4.4B | 4.5B | 3.7B | 3.1B | 2.7B | 2.4B | 2.1B | 2.3B | 2.2B | 1.8B | 1.4B | 1.1B | 874.9M | 600.8M | 372.7M | |
GROSS PROFIT | ||||||||||||||||||||
(3.4B) | (2.7B) | (2.4B) | (2B) | (1.8B) | (1.5B) | (1.4B) | (1.1B) | (934.8M) | (814.3M) | (806.5M) | (717.9M) | (670.9M) | (608.5M) | (483.5M) | (383M) | (301.1M) | (254.1M) | (186.5M) | (124.8M) | |
6.6B | 5.6B | 4.7B | 4.2B | 4B | 2.9B | 3.1B | 2.6B | 2.2B | 1.9B | 1.6B | 1.4B | 1.6B | 1.6B | 1.3B | 1B | 751.1M | 620.8M | 414.3M | 247.8M | |
OPERATING INCOME | ||||||||||||||||||||
(3.7B) | (3.3B) | (3B) | (2.6B) | (2.1B) | (1.8B) | (1.7B) | (1.4B) | (1.1B) | (944.9M) | (837.9M) | (869M) | (741.7M) | (692.2M) | (579M) | (474.8M) | (373.6M) | (309.9M) | (207.5M) | (140.5M) | |
(2.4B) | (2.1B) | (2B) | (1.7B) | (1.5B) | (1.2B) | (1.2B) | (986.6M) | (810.9M) | (705.3M) | (640.5M) | (691M) | (574M) | (522.2M) | (438.8M) | (358.8M) | (278.5M) | (230.6M) | (158.7M) | (110.7M) | |
(1.3B) | (1.1B) | (998.8M) | (879M) | (671M) | (595.1M) | (557.3M) | (418.1M) | (328.6M) | (239.6M) | (197.4M) | (178M) | (167.7M) | (170M) | (140.2M) | (116M) | (95.1M) | (79.4M) | (48.9M) | (29.8M) | |
2.9B | 2.3B | 1.8B | 1.6B | 1.8B | 1B | 1.4B | 1.2B | 1.1B | 945.2M | 740M | 544.8M | 852.5M | 878.1M | 694.8M | 555.2M | 377.4M | 310.8M | 206.7M | 107.4M | |
PRE-TAX INCOME | ||||||||||||||||||||
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (15.8M) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
365.9M | 324.9M | 192.1M | 29.7M | 69.3M | 157.2M | 127.7M | 80.1M | 41.9M | 35.6M | 18.5M | 13.9M | 18.4M | 15.8M | 14.9M | 16.6M | 18.7M | 0.0 | 0.0 | 0.0 | |
365.9M | 324.9M | 192.1M | 29.7M | 69.3M | 157.2M | 127.7M | 80.1M | 41.9M | 35.6M | 18.5M | 4.2M | 18.4M | 15.8M | 14.9M | 17.1M | 18.7M | 24.4M | 30.5M | 12.8M | |
3.3B | 2.7B | 2B | 1.6B | 1.9B | 1.2B | 1.5B | 1.3B | 1.1B | 980.8M | 758.5M | 549M | 870.9M | 893.9M | 709.7M | 572.3M | 396.1M | 335.2M | 237.2M | 120.1M | |
NET INCOME | ||||||||||||||||||||
(434.8M) | (336.3M) | (141.6M) | (262.4M) | (162.2M) | (140.2M) | (120.4M) | (154.5M) | (436.5M) | (244.9M) | (169.7M) | (130.2M) | (199.9M) | (237.3M) | (214.6M) | (190.5M) | (163.5M) | (130.9M) | (92.7M) | (48.1M) | |
2.9B | 2.3B | 1.8B | 1.3B | 1.7B | 1.1B | 1.4B | 1.1B | 660M | 735.9M | 588.8M | 418.8M | 671M | 656.6M | 495.1M | 381.8M | 232.6M | 204.3M | 144.5M | 72M |
SEC Filings
ISRG - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 28, 2026 | May 28, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 04, 2026 | April 30, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | April 22, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 21, 2026 | April 21, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | March 13, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 02, 2026 | March 01, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 03, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | January 22, 2026 | January 22, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 14, 2026 | January 14, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 18, 2025 | December 16, 2025 | 2025 |
Related Guides
Continue your ISRG research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.